Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.
Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes coated particles, pellets, or tablets. Swelling-controlled reservoir systems use polymers such as HPMC. Drug release begins only after the membrane hydrates, resulting in a delayed and steady release rate.
Matrix systems incorporate the drug within a release-retarding material. Hydrophilic matrices use water-swellable polymers like HPMC, HPC, xanthan gum, or PEO. These form porous structures and can be free-swelling or restricted-swelling depending on whether hydration is unhindered or partially limited by an external coating. Hydrophobic matrices use materials that are either slowly soluble or completely insoluble, such as waxes or ethyl cellulose. These can be porous, where drug and polymer particles are mixed, or nonporous, where the drug is melted into the polymer. Nonporous types include dissolved and dispersed drug systems based on drug solubility.
Hybrid systems combine matrix and reservoir designs. The drug is embedded in a matrix and further coated with a polymer membrane. This design merges the consistent drug release of reservoir systems with the structural durability of matrix systems, allowing better control over drug delivery. These systems are tailored based on drug properties, release rate requirements, and treatment goals.
Rate-programmed drug delivery systems can follow three designs: reservoir, matrix, or hybrid.
Reservoir systems enclose the drug core within a rate-controlling film or membrane.
Non-swelling types use ethyl cellulose and polymethacrylate polymers to control drug release through thickness, insolubility, slow dissolution, or porosity. Swelling-controlled types often use polymers like HPMC to delay drug release until membrane hydration.
Matrix systems embed the drug in a release-retarding material.
Hydrophilic matrices use swellable polymers like HPMC, while hydrophobic matrices use waxes or ethyl cellulose. Hydrophobic matrices can be porous, with the drug mixed into the polymer, or nonporous, with the drug dispersed in molten polymer.
Hybrid systems embed the drug in a matrix coated with a release-retarding material, which is further coated with a release-controlling polymer. This design combines the steady release of reservoir systems with the durability of matrix devices, effectively controlling drug release.
繁體中文
